Nuance Medical acquired Biocorneum, a state-of-the-art silicone gel scar treatment brand, from Sientra.WHO: Recognized for over 30 years of innovation and effectiveness in scar management, Biodermis has been at the forefront of medical-grade silicone treatments for over three decades. Known for its dedication to quality and innovation, Biodermis is a trusted name among healthcare providers for effective, non-invasive scar management solutions.Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. Headquartered in Carlsbad, California, Nuance Medical is a leading designer, developer, and marketer of branded and private-label medical products. The company, formed in 2013, develops innovative products for underserved, niche markets in the healthcare sector. Nuance's capabilities include product development, sales, and marketing expertise.WHY: This strategic move enhances Biodermis’ commitment to providing top-tier skincare solutions to healthcare professionals.IN THEIR OWN WORDS: “Bringing Biocorneum into the Biodermis family marks a significant step in our journey to lead with innovative and impactful treatments in scar management," said Mark Steele, President of Nuance Medical.